Switch Maintenance versus Second-Line Treatment in Non-small Cell Lung Cancer

被引：0
|
作者：
Rossi, Antonio [1 ]
Torri, Valter [2 ]
Gridelli, Cesare [1 ]
机构：
[1] SG Moscati Hosp, Div Med Oncol, I-83100 Avellino, Italy
[2] Mario Negri Inst Pharmacol Res, Dept Oncol, Lab New Drug Dev Strategies, Milan, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 07期
关键词：
D O I：
10.1097/JTO.0b013e31821f9f0d
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1298 / 1298
页数：1
相关论文
共 50 条
  • [1] Racotumomab in Non-Small Cell Lung Cancer as Maintenance and Second-Line Treatment
    Caceres-Lavernia, Haslen H.
    Neninger-Vinageras, Elia
    Varona-Rodriguez, Leslie M.
    Olivares-Romero, Yoli A.
    Sanchez-Rojas, Irlis
    Mazorra-Herrera, Zaima
    Basanta-Bergolla, Denenke
    Duvergel-Calderin, Dayanis
    Torres-Cuevas, Boris L.
    del Castillo-Carrillo, Concepcion
    MEDICC REVIEW, 2021, 23 (3-4) : 21 - 28
  • [2] Advanced non-small cell lung cancer. Maintenance and second-line treatment
    Schuette, W.
    Nagel, S.
    Haak, G.
    Steinert, M.
    PNEUMOLOGE, 2012, 9 (01): : 43 - 48
  • [3] Second-line treatment of advanced non-small cell lung cancer
    Gridelli, Cesare
    Ardizzoni, Andrea
    Ciardiello, Fortunato
    Hanna, Nasser
    Heymach, John V.
    Perrone, Francesco
    Rosell, Rafael
    Shepherd, Frances A.
    Thatcher, Nick
    Vansteenkiste, Johan
    De Petris, Luigi
    Di Maio, Massimo
    De Marinis, Filippo
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 430 - 440
  • [4] Single agents in the second-line treatment of non-small cell lung cancer
    Belani, CP
    SEMINARS IN ONCOLOGY, 1998, 25 (03) : 10 - 14
  • [5] Geographic variation in the second-line treatment of non-small cell lung cancer
    Edelman, MJ
    Sekine, I
    Tamura, T
    Saijo, N
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : S39 - S44
  • [6] An evaluation of pemetrexed in second-line treatment of non-small cell lung cancer
    Scagliotti, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (16) : 2855 - 2866
  • [7] The safety of second-line treatment options for non-small cell lung cancer
    Rossi, Antonio
    Maione, Paolo
    Santabarbara, Giuseppe
    Sacco, Paola Claudia
    Casaluce, Francesca
    Sgambato, Assunta
    Barzelloni, Maria Luisa
    Palazzolo, Giovanni
    Gridelli, Cesare
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (04) : 471 - 479
  • [8] Docetaxel and carboplatin as the second-line treatment of non-small cell lung cancer
    Pesek, M
    Holá, V
    LUNG CANCER: CURRENT TOPICS, 2001, : 155 - 160
  • [9] Second-line treatment options in advanced non-small cell lung cancer
    de Marinis, Filippo
    Ricciardi, Serena
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S258 - S271
  • [10] Future directions in the second-line treatment of non-small cell lung cancer
    Rosell, R
    Cecere, F
    Cognetti, F
    Cuello, M
    Sanchez, JM
    Taron, M
    Reguart, N
    Jablons, D
    SEMINARS IN ONCOLOGY, 2006, 33 (01) : S45 - S51
12345